MIT researchers find genetic blockade technique to potentialy treat Alzheimer's disease

636 views · Published 17 September 2017 · 0:53 · Indexed 26 October 2026

Channel: News Direct · 2017 · News & Politics

Watch on YouTube

Contact [email protected] to license this or any News Direct video
For story suggestions please contact [email protected]

RESTRICTIONS: NONE

Researchers at MIT have discovered a new potential treatment for Alzheimer's disease which involves the interference of an enzyme that forms blockades in brain cells.

Scientists have discovered that levels of HDAC2 enzyme are usually higher in people with Alzheimer's. Medical mice with the disease also have elevated levels of this enzyme.

HDAC2 binds to a gene called Sp3, which condenses chromatin and reduces the expression of some genes in the DNA that results in blocking memory formation.

Researchers at MIT's Picower Institute for Learning and Memory identified the particular section of HDAC2 that binds to Sp3, and overproduced that fragment. The fragment binds to Sp3, preventing it from binding to entire HDAC2 enzymes, thus allowing the expression of memory-linked genes.

"This is exciting because for the first time we have found a specific mechanism by which HDAC2 regulates synaptic gene expression," Li-Huei Tsai, director of MIT's Picower Institute for Learning and Memory and the study's senior author said in a press release.

Previous attempts at blocking HDAC2 would often trigger dangerous side effects by interfering with the production of red and white blood cells. MIT's technique is the first known procedure to have shown no interference with other enzymes. Researchers are investigating other ways to adapt the technique in human trials.

The study was published in the journal Cell Reports.

RUNDOWN SHOWS:
1. High levels of HDAC2 found in Alzheimer's stricken mouse
2. HDAC2 binds to Sp3 and causes chromatin to condense
3. Particular section of HDAC2 that binds to Sp3 identified and mass produced
4. The fragment binds to Sp3 instead of HDAC2

VOICEOVER (in English): 

"It has been discovered that levels of HDAC2 enzyme are usually higher in people with Alzheimer's and also in mouse models of the disease."

"HDAC2 binds to a gene called Sp3, which condenses chromatin and reduces the expression of some genes in the DNA that results in blocking memory formation."

"Researchers identified the particular section of HDAC2 that binds to Sp3, and overproduced that fragment."

"The fragment binds to Sp3, preventing it from binding to HDAC2 and releasing the blockade of memory-linked genes."

SOURCES: Cell Reports, MIT News, New Atlas, Medical News Today
http://www.cell.com/cell-reports/fulltext/S2211-1247(17)31023-9
http://news.mit.edu/2017/blocking-key-enzyme-may-reverse-memory-loss-0808
http://newatlas.com/alzheimers-memory-loss-reversed-mice/50822/
http://www.medicalnewstoday.com/articles/318872.php


***
For story suggestions please contact [email protected]
For technical and editorial support, please contact:
Asia: +61 2 93 73 1841
Europe: +44 20 7542 7599
Americas and Latam: +1 800 738 8377
----------------------------------------­­---------------------------------------­-­----------------

Next Animation Studio’s News Direct service provides daily, high-quality, informative 3D news animations that fill in for missing footage and help viewers understand breaking news stories or in-depth features on science, technology, and health.

Sign up for a free trial of News Direct's news animations at http://newsdirect.nextanimationstudio.com/trial/

To subscribe to News Direct or for more info, please visit:
http://newsdirect.nextanimationstudio.com

More from this channel